PTP4A3 and chronic myelogenous leukemia, BCR-ABL1 positive: To establish a connection between BCR-ABL signalling and PRL-3 expression, we treated human CML cell lines, K562 and KCL-22 cells with Imatinib and assessed the expression of PRL-3.